EE201300005A - Ravimkoostis - Google Patents
RavimkoostisInfo
- Publication number
- EE201300005A EE201300005A EEP201300005A EEP201300005A EE201300005A EE 201300005 A EE201300005 A EE 201300005A EE P201300005 A EEP201300005 A EE P201300005A EE P201300005 A EEP201300005 A EE P201300005A EE 201300005 A EE201300005 A EE 201300005A
- Authority
- EE
- Estonia
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Mycology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010129289/15A RU2552221C2 (ru) | 2010-07-15 | 2010-07-15 | Способ лечения ожирения и сопутствующих метаболических расстройств и лекарственное средство для лечения ожирения и сопутствующих метаболических расстройств |
| RU2010130350/15A RU2533224C2 (ru) | 2010-07-21 | 2010-07-21 | Способ лечения зависимости от психоактивных веществ, алкоголизма и табакокурения и лекарственное средство для лечения зависимости от психоактивных веществ, алкоголизма и табакокурения |
| RU2011122407A RU2610438C2 (ru) | 2011-06-02 | 2011-06-02 | Способ лечения патологического синдрома и лекарственное средство центрального и периферического действия для лечения патологического синдрома |
| PCT/IB2011/002404 WO2012007847A2 (en) | 2010-07-15 | 2011-07-15 | Pharmaceutical compositions and methods of treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE201300005A true EE201300005A (et) | 2013-08-15 |
| EE05760B1 EE05760B1 (et) | 2016-03-15 |
Family
ID=44899164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP201300005A EE05760B1 (et) | 2010-07-15 | 2011-07-15 | Ravimkoostis |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US8865163B2 (et) |
| EP (1) | EP2593477A2 (et) |
| JP (1) | JP2013535436A (et) |
| KR (1) | KR20140012009A (et) |
| CN (1) | CN103124742A (et) |
| AR (1) | AR082246A1 (et) |
| AU (1) | AU2011278040B2 (et) |
| BR (1) | BR112013000841A2 (et) |
| CA (1) | CA2805091A1 (et) |
| CL (1) | CL2013000098A1 (et) |
| CZ (1) | CZ2013104A3 (et) |
| DE (1) | DE112011102349T5 (et) |
| DK (1) | DK201370078A (et) |
| EA (1) | EA029400B1 (et) |
| EE (1) | EE05760B1 (et) |
| ES (1) | ES2542042R1 (et) |
| FI (1) | FI20135146L (et) |
| FR (1) | FR2962653A1 (et) |
| GB (1) | GB2496076B (et) |
| IT (1) | ITTO20110641A1 (et) |
| LT (1) | LT5987B (et) |
| MX (1) | MX361778B (et) |
| MY (1) | MY158183A (et) |
| NO (1) | NO20130219A1 (et) |
| NZ (1) | NZ606768A (et) |
| PE (1) | PE20131338A1 (et) |
| PH (1) | PH12013500109A1 (et) |
| SE (1) | SE1350179A1 (et) |
| SG (1) | SG187037A1 (et) |
| WO (1) | WO2012007847A2 (et) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| EA030566B1 (ru) | 2010-07-15 | 2018-08-31 | Олег Ильич ЭПШТЕЙН | Способ повышения терапевтической эффективности активированной-потенцированной формы антитела к эндогенной биомолекуле и фармацевтическая композиция |
| CN103282384A (zh) * | 2010-07-15 | 2013-09-04 | 奥列格·伊里奇·爱泼斯坦 | 复合药物组合物以及对泌尿生殖系统障碍进行治疗的方法 |
| US8637034B2 (en) | 2010-07-15 | 2014-01-28 | Oleg I. Epshtein | Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein |
| CA2805963A1 (en) | 2010-07-21 | 2012-01-26 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| KR20130102542A (ko) * | 2010-07-21 | 2013-09-17 | 올레그 일리치 엡쉬테인 | 현기증, 동요병 및 증식형-혈관 이긴장증 치료용 제약학적 복합 조성물 및 치료 방법들 |
| EP3693018A1 (en) * | 2010-07-21 | 2020-08-12 | Oleg Iliich Epshtein | A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders |
| PH12013500142A1 (en) * | 2010-07-21 | 2013-03-11 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition |
| WO2012017328A2 (en) * | 2010-08-06 | 2012-02-09 | Oleg Iliich Epshtein | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
| RU2013111962A (ru) * | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| RU2013111961A (ru) * | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| MX2016012403A (es) * | 2014-03-27 | 2017-06-14 | Bird Rock Bio Inc | Anticuerpos que se unen al receptor cannabinoide 1 (cb1) humano. |
| CN104524568B (zh) * | 2015-01-08 | 2018-04-20 | 中国人民解放军第二军医大学 | 一种治疗肥胖症的药物组合物及其应用 |
| PE20181199A1 (es) | 2015-09-30 | 2018-07-23 | Bird Rock Bio Inc | Anticuerpos que se unen al receptor cannabinoide 1 (cb1) humano |
| JP2022545178A (ja) * | 2019-08-29 | 2022-10-26 | イリイチ・エプシテイン オレグ | 感染症を治療するための医薬及び方法 |
| CH721975A1 (de) * | 2024-07-15 | 2026-01-30 | Ilyich Epshtein Oleg | Verfahren für den Erhalt von Kosmetik- und therapeutischen Kosmetikmitteln |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
| CN1141929C (zh) | 1996-02-12 | 2004-03-17 | O·I·伊普施廷 | 药物制剂 |
| US5849528A (en) | 1997-08-21 | 1998-12-15 | Incyte Pharmaceuticals, Inc.. | Polynucleotides encoding a human S100 protein |
| RU2156621C1 (ru) | 1999-03-04 | 2000-09-27 | Эпштейн Олег Ильич | Нейротропное лекарственное средство |
| RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2209084C1 (ru) * | 2001-12-26 | 2003-07-27 | Эпштейн Олег Ильич | Лекарственное средство и способ лечения депрессивных расстройств |
| RU2201255C1 (ru) | 2001-12-26 | 2003-03-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции сосудистого тонуса |
| UA76641C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
| UA76639C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| UA76640C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Спосіб корекції патологічних імунних реакцій та гомеопатичний лікарський засіб |
| CA2518965C (en) | 2003-03-14 | 2018-10-30 | Nutrition Research Inc. | Homeopathic formulations useful for treating pain and/or inflammmation |
| US20050100513A1 (en) | 2003-11-10 | 2005-05-12 | Watkins Mary B. | Homeopathic method and system for treating nicotine addiction |
| EP1574211A1 (en) * | 2004-03-09 | 2005-09-14 | Inserm | Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| RU2437678C2 (ru) | 2006-06-06 | 2011-12-27 | Олег Ильич Эпштейн | Лекарственное средство для перорального лечения ожирения и способ получения твердой лекарственной формы для пероральной терапии ожирения |
| RU2438707C2 (ru) | 2006-06-06 | 2012-01-10 | Олег Ильич Эпштейн | Лекарственное средство для перорального лечения сахарного диабета и других заболеваний, сопровождающихся нарушением толерантности к глюкозе, и способ получения твердой лекарственной формы для пероральной терапии сахарного диабета и других заболеваний, сопровождающихся нарушением толерантности к глюкозе |
| EA200802440A1 (ru) * | 2006-06-06 | 2009-06-30 | Олег Ильич ЭПШТЕЙН | Лекарственное средство для лечения ожирения, сахарного диабета и заболеваний с нарушением толерантности к глюкозе |
| TW200825067A (en) * | 2006-10-23 | 2008-06-16 | Lilly Co Eli | CB1 compounds |
| EP1985295A1 (en) * | 2007-04-04 | 2008-10-29 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Selective inhibitors of CB2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders |
| JP2010132631A (ja) * | 2008-11-04 | 2010-06-17 | Bizen Chemical Co Ltd | カンナビノイド受容体のインバースアゴニストおよびアンタゴニスト活性を有する組成物 |
| EA030542B1 (ru) | 2010-07-15 | 2018-08-31 | Олег Ильич ЭПШТЕЙН | Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний желудочно-кишечного тракта функциональной этиологии |
| US8637034B2 (en) * | 2010-07-15 | 2014-01-28 | Oleg I. Epshtein | Pharmaceutical compositions comprising activated-potentiated antibodies to interferon-gamma and S100 protein |
| CA2805963A1 (en) | 2010-07-21 | 2012-01-26 | Oleg Iliich Epshtein | A method of treating attention deficit hyperactivity disorder |
| GB2496801B (en) | 2010-07-21 | 2018-04-11 | Iliich Epshtein Oleg | A method of treating alzheimer's disease |
| KR20130102542A (ko) | 2010-07-21 | 2013-09-17 | 올레그 일리치 엡쉬테인 | 현기증, 동요병 및 증식형-혈관 이긴장증 치료용 제약학적 복합 조성물 및 치료 방법들 |
| EP3693018A1 (en) | 2010-07-21 | 2020-08-12 | Oleg Iliich Epshtein | A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders |
| ITTO20110634A1 (it) | 2010-07-21 | 2012-01-22 | Oleg Iliich Epshtein | Metodo per trattare patologie organiche del sistema nervoso, la sindrome psicoorganica e l'encefalopatia |
-
2011
- 2011-07-15 IT IT000641A patent/ITTO20110641A1/it unknown
- 2011-07-15 NZ NZ606768A patent/NZ606768A/en not_active IP Right Cessation
- 2011-07-15 PE PE2013000073A patent/PE20131338A1/es not_active Application Discontinuation
- 2011-07-15 FR FR1156473A patent/FR2962653A1/fr not_active Withdrawn
- 2011-07-15 SE SE1350179A patent/SE1350179A1/sv unknown
- 2011-07-15 CA CA2805091A patent/CA2805091A1/en not_active Abandoned
- 2011-07-15 FI FI20135146A patent/FI20135146L/fi not_active IP Right Cessation
- 2011-07-15 EP EP11788222.5A patent/EP2593477A2/en not_active Ceased
- 2011-07-15 BR BR112013000841A patent/BR112013000841A2/pt not_active IP Right Cessation
- 2011-07-15 DE DE112011102349T patent/DE112011102349T5/de not_active Ceased
- 2011-07-15 KR KR1020137003750A patent/KR20140012009A/ko not_active Ceased
- 2011-07-15 SG SG2013002316A patent/SG187037A1/en unknown
- 2011-07-15 EA EA201300133A patent/EA029400B1/ru not_active IP Right Cessation
- 2011-07-15 US US13/135,893 patent/US8865163B2/en not_active Expired - Fee Related
- 2011-07-15 PH PH1/2013/500109A patent/PH12013500109A1/en unknown
- 2011-07-15 JP JP2013519178A patent/JP2013535436A/ja active Pending
- 2011-07-15 ES ES201390003A patent/ES2542042R1/es active Pending
- 2011-07-15 MX MX2013000545A patent/MX361778B/es active IP Right Grant
- 2011-07-15 CN CN2011800442270A patent/CN103124742A/zh active Pending
- 2011-07-15 AU AU2011278040A patent/AU2011278040B2/en not_active Ceased
- 2011-07-15 CZ CZ20130104A patent/CZ2013104A3/cs unknown
- 2011-07-15 GB GB1302653.9A patent/GB2496076B/en not_active Expired - Fee Related
- 2011-07-15 EE EEP201300005A patent/EE05760B1/et not_active IP Right Cessation
- 2011-07-15 MY MYPI2013000110A patent/MY158183A/en unknown
- 2011-07-15 WO PCT/IB2011/002404 patent/WO2012007847A2/en not_active Ceased
- 2011-07-18 AR ARP110102576A patent/AR082246A1/es unknown
-
2013
- 2013-01-10 CL CL2013000098A patent/CL2013000098A1/es unknown
- 2013-02-08 NO NO20130219A patent/NO20130219A1/no not_active Application Discontinuation
- 2013-02-14 DK DKPA201370078A patent/DK201370078A/da not_active Application Discontinuation
- 2013-02-14 LT LT2013015A patent/LT5987B/lt not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201700008B (it) | Composizione farmaceutica | |
| SMT201600350B (it) | Composizioni farmaceutiche | |
| DK3246018T3 (da) | Farmaceutisk sammensætning | |
| DK2694038T3 (da) | Farmaceutisk sammensætning | |
| DK3097925T3 (da) | Farmaceutisk sammensætning | |
| BR112012031667A2 (pt) | composição | |
| BRPI1004940A2 (pt) | composição farmacêutica | |
| BR112014003052A2 (pt) | composições farmacêuticas | |
| SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
| DK2654736T3 (da) | Hidtil ukendt farmaceutisk sammensætning | |
| BR112012032683A2 (pt) | composição | |
| CO6930367A2 (es) | Composiciones farmaceúticas | |
| BRPI1015939A2 (pt) | composição farmacêutica | |
| GT201200303A (es) | Formulaciones farmacéuticas | |
| EP2636704A4 (en) | FILM FORMING COMPOSITION | |
| LT2865271T (lt) | Pagerinta kompozicija | |
| HUE040370T2 (hu) | Gyógyszerkészítmények | |
| EP2642979A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP2628769A4 (en) | FILM FORMING COMPOSITION | |
| BR112012032980A2 (pt) | composição | |
| EP2635269A4 (en) | COMBINATION COMPOSITION | |
| CO6801722A2 (es) | Composiciones farmacéuticas | |
| EP2624836A4 (en) | BEPOTASTIN COMPOSITION | |
| EP2769718A4 (en) | MEDICAL COMPOSITION | |
| BR112013008074A2 (pt) | combinações farmacêuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20180715 |